Hemab Launches With ‘Pipeline In An Asset’ Approach To Rare Blood Disorders

Raises $55m In Series A

Emerging Company Profile: Hemab
• Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Emerging Company Profiles

More from Start-Ups & SMEs